NCT04334213View on ClinicalTrials.gov

A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D745 and D150

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 7, 2020

Primary Completion Date

August 5, 2020

Study Completion Date

August 5, 2020

Conditions
Type 2 Diabetes
Interventions
DRUG

CKD-501

QD, PO

DRUG

D745, D150

QD, PO

DRUG

CKD-501, D745, D150

QD, PO

Trial Locations (1)

Unknown

Severance Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT04334213 - A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D745 and D150 | Biotech Hunter | Biotech Hunter